List of Excipients in API CINACALCET HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing CINACALCET HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| A-S Medication Solutions | SENSIPAR | cinacalcet hydrochloride | 50090-3529 | CARNAUBA WAX | |
| A-S Medication Solutions | SENSIPAR | cinacalcet hydrochloride | 50090-3529 | CELLULOSE, MICROCRYSTALLINE | |
| A-S Medication Solutions | SENSIPAR | cinacalcet hydrochloride | 50090-3529 | CROSPOVIDONE | |
| A-S Medication Solutions | SENSIPAR | cinacalcet hydrochloride | 50090-3529 | MAGNESIUM STEARATE | |
| A-S Medication Solutions | SENSIPAR | cinacalcet hydrochloride | 50090-3529 | POVIDONE | |
| A-S Medication Solutions | SENSIPAR | cinacalcet hydrochloride | 50090-3529 | SILICON DIOXIDE | |
| A-S Medication Solutions | SENSIPAR | cinacalcet hydrochloride | 50090-3529 | STARCH, CORN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing CINACALCET HYDROCHLORIDE
Detailed excipient profiles for CINACALCET HYDROCHLORIDE
Excipient focus: CARNAUBA WAX
CINACALCET HYDROCHLORIDE drug variants containing CARNAUBA WAX
CINACALCET HYDROCHLORIDE drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Slate Run Pharmaceuticals | cinacalcet hydrochloride | 70436-007 |
| ACI Healthcare USA Inc | cinacalcet hydrochloride | 71093-152 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
CINACALCET HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
CINACALCET HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
CINACALCET HYDROCHLORIDE drug variants containing CROSPOVIDONE
CINACALCET HYDROCHLORIDE drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
CINACALCET HYDROCHLORIDE drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Slate Run Pharmaceuticals | cinacalcet hydrochloride | 70436-007 |
| >Company | >Ingredient | >NDC |
CINACALCET HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FERRIC OXIDE YELLOW
CINACALCET HYDROCHLORIDE drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Slate Run Pharmaceuticals | cinacalcet hydrochloride | 70436-007 |
| >Company | >Ingredient | >NDC |
CINACALCET HYDROCHLORIDE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYPROMELLOSE 2208
CINACALCET HYDROCHLORIDE drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Slate Run Pharmaceuticals | cinacalcet hydrochloride | 70436-007 |
| >Company | >Ingredient | >NDC |
CINACALCET HYDROCHLORIDE drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
CINACALCET HYDROCHLORIDE drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| ACI Healthcare USA Inc | cinacalcet hydrochloride | 71093-152 |
| >Company | >Ingredient | >NDC |
CINACALCET HYDROCHLORIDE drug variants not containing HYPROMELLOSE 2910
Excipient focus: LACTOSE MONOHYDRATE
CINACALCET HYDROCHLORIDE drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Slate Run Pharmaceuticals | cinacalcet hydrochloride | 70436-007 |
| ACI Healthcare USA Inc | cinacalcet hydrochloride | 71093-152 |
| >Company | >Ingredient | >NDC |
CINACALCET HYDROCHLORIDE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
CINACALCET HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE
CINACALCET HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| ACI Healthcare USA Inc | cinacalcet hydrochloride | 71093-152 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
CINACALCET HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| ACI Healthcare USA Inc | cinacalcet hydrochloride | 71093-152 |
| >Company | >Ingredient | >NDC |
CINACALCET HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POVIDONE
CINACALCET HYDROCHLORIDE drug variants containing POVIDONE
CINACALCET HYDROCHLORIDE drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | cinacalcet hydrochloride | 68151-4740 |
| Slate Run Pharmaceuticals | cinacalcet hydrochloride | 70436-007 |
| ACI Healthcare USA Inc | cinacalcet hydrochloride | 71093-152 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONES
CINACALCET HYDROCHLORIDE drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | cinacalcet hydrochloride | 68151-4740 |
| >Company | >Ingredient | >NDC |
CINACALCET HYDROCHLORIDE drug variants not containing POVIDONES
Excipient focus: SILICON DIOXIDE
CINACALCET HYDROCHLORIDE drug variants containing SILICON DIOXIDE
CINACALCET HYDROCHLORIDE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
CINACALCET HYDROCHLORIDE drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| ACI Healthcare USA Inc | cinacalcet hydrochloride | 71093-152 |
| >Company | >Ingredient | >NDC |
CINACALCET HYDROCHLORIDE drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STARCH, CORN
CINACALCET HYDROCHLORIDE drug variants containing STARCH, CORN
CINACALCET HYDROCHLORIDE drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
CINACALCET HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Slate Run Pharmaceuticals | cinacalcet hydrochloride | 70436-007 |
| ACI Healthcare USA Inc | cinacalcet hydrochloride | 71093-152 |
| >Company | >Ingredient | >NDC |
CINACALCET HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
CINACALCET HYDROCHLORIDE drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Slate Run Pharmaceuticals | cinacalcet hydrochloride | 70436-007 |
| ACI Healthcare USA Inc | cinacalcet hydrochloride | 71093-152 |
| >Company | >Ingredient | >NDC |
CINACALCET HYDROCHLORIDE drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
